Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Renstrom F et al. - The present findings indicate the presence of biomolecules in the circulation of type 2 diabetic subjects, apart from glucose, insulin, and free fatty acids with the ability to induce peripheral insulin resistance.

Related Articles

Role of glucotoxicity and lipotoxicity in the pathophysiology of Type 2 diabetes mellitus and emerging treatment strategies
Diabetic Medicine, 11/25/09    Relevance Score: 83%%

Alternative Forms of Exercise Training as Complementary Therapy in the Prevention and Management of Type 2 Diabetes
Diabetes Spectrum, 11/24/09    Relevance Score: 83%%

Lipid and inflammatory biomarkers and kidney function decline in type 2 diabetes
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 11/23/09    Relevance Score: 83%%

Increasing BMI and waist circumference and prevalence of obesity among adults with Type 2 diabetes: the National Health and Nutrition Examination Surveys
Journal of Diabetes and its Complications, 11/17/09    Relevance Score: 83%%

The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 11/09/09    Relevance Score: 83%%

Today in Diabetes...keeping you current

Angiotensin II Type 1 and Type 2 Receptors Regulate Basal Skeletal Muscle Microvascular Volume and Glucose Use
Hypertension, 12/08/09

Metabolic Syndrome and Solid-Organ Transplantation
American Journal of Transplantation, 12/08/09

Advanced Glycation End-Products Induce Tubular CTGF via TGF-[beta]–Independent Smad3 Signaling
Journal of the American Society of Nephrology, 12/08/09

Today in Pharmacology/kinetics...keeping you current

Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing's disease
Pituitary, 12/08/09

Pioglitazone and mechanisms of CV protection
QJM: An International Journal of Medicine, 12/08/09

Rosiglitazone was non-inferior to metformin plus sulphonylurea for CV events but increased risk of HF and fractures in type 2 diabetes
Evidence-Based Medicine, 12/07/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address